Skip to content

Retrospective Analysis of Quality of Life Changes in Patients Undergoing Parathyroidectomy for End-Stage Renal Disease

Quality of Life Change in Patients Undergoing Parathyroidectomy With Secondary Hyperparathyroidism Due toEnd-stage Renal Failure: a Retrospective Cohort Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07151664
Enrollment
60
Registered
2025-09-03
Start date
2025-09-05
Completion date
2026-12-20
Last updated
2025-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Failure, Secondary Hyperparathyroidism Due to Renal Causes

Brief summary

The purpose of this study is to characterize changes in quality of life in patients who had undergone parathyroidectomy for secondary hyperparathyroidism due to end-stage renal disease, based on data extracted from an established database

Detailed description

Data were retrospectively collected from an established database of patients who underwent surgery for renal secondary hyperparathyroidism (SHPT). Extracted information included demographic and clinical characteristics (age, gender, education level, clinical symptoms), baseline quality of life assessed by the 36-item Short-Form Health Survey (SF-36), and completed follow-up assessments of SF-36 scores, depression, and anxiety at one, three, six months, and one year postoperatively.

Interventions

Study the progression of quality of life

Sponsors

West China Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Age ≥18 years; Patients who had undergone parathyroidectomy for secondary hyperparathyroidism due to end-stage renal disease.

Exclusion criteria

Patients who underwent kidney transplantation during the study period. Patients with postoperative whole blood parathyroid hormone levels \>300 pg/mL within the first week after surgery. Patients with missing postoperative quality of life assessment data.

Design outcomes

Primary

MeasureTime frameDescription
Quality of life scores change with respect to timeup to 1 yearQuality of life was assessed using the 36-item Short Form Health Survey (SF-36) scale. Completed responses for each of the 36 items were extracted from the database. Item responses were aggregated to calculate scores for each of the eight dimensions. Scores for each dimension range from 0 to 100, with higher scores indicating better health status

Secondary

MeasureTime frameDescription
Anxiety and depression score change with respect to timeup to 1 yearAnxiety and depression were evaluated using the Hospital Anxiety and Depression Scale (HADS). Completed responses for the 14-item HADS, comprising 7 items each for the anxiety (HADS-A) and depression (HADS-D) subscales, were extracted from the database. Item scores range from 0 to 3, and were summed to yield separate scores for anxiety and depression
Bone pain scores change with respect to timeup to 1 yearBone pain was evaluated using the Numerical Rating Scale (NRS). Completed NRS scores, ranging from 0 to 10, were extracted from the database. In this scale, 0 represents no pain, 1-3 represents mild pain, 4-6 represents moderate pain, 7-9 represents severe pain, and 10 represents the worst pain
Length of hospital stayan average of 1 week

Contacts

Primary ContactChunling Jiang, PhD
jiangchunling@scu.edu.cn+862885423593

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026